17.01.2015 Views

Vol 43 # 2 June 2011 - Kma.org.kw

Vol 43 # 2 June 2011 - Kma.org.kw

Vol 43 # 2 June 2011 - Kma.org.kw

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

118<br />

KUWAIT MEDICAL JOURNAL<br />

<strong>June</strong> <strong>2011</strong><br />

Original Article<br />

Pattern of Chromosomal Abnormalities in Pediatric<br />

Acute Lymphoblastic Leukemia (ALL)<br />

Padhi Somanath 1 , Sarangi RajLaxmi 2 , Mohanty Pranati 1 , Das Rupa 1 , Chakravarty Sukumar 1 , Mohanty Raghumani 1<br />

1<br />

Department of Pathology, Sriram Chandra Bhanja Medical College and Hospital, Cuttack, Odisha, India<br />

2<br />

Department of Biochemistry, Maharaja Krushna Chandra Gajapati Medical College and Hospital, Berhampur, Odisha,<br />

India<br />

Kuwait Medical Journal <strong>2011</strong>; <strong>43</strong> (2): 118-124<br />

ABSTRACT<br />

Objective: To study the cytogenetic profile of newly<br />

diagnosed patients with pediatric acute lymphoblastic<br />

leukemia (ALL)<br />

Design: Prospective case control study<br />

Setting: Tertiary care hospital in India<br />

Subjects: Newly diagnosed patients with pediatric ALL<br />

Interventions: Karyotype analysis of bone marrow aspirate<br />

samples by routine G-Banding technique and analysis as per<br />

International System for Cytogenetic Nomenclature (ISCN),<br />

2005 criteria.<br />

Main Outcome Measures: Cytogenetic parameters<br />

Results: The study included 23 male and eight female patients<br />

(M:F = 2.8:1). ALL-L2 was the most common morphological<br />

phenotype (18 / 31, 58%). Sixteen out of thirty one (51.6%)<br />

patients were hypodiploid (2n < 46), 10 / 31(32.0%)<br />

hyperdiploid (2n > 46) and 5 / 31(16.0%) aneuploid. Among<br />

hypodiploid groups, nine (29.0%) had modal chromosome<br />

number as 40-45, five (16.0%) as 31-39 and two (6.5%) as<br />

25-30. Among hyperdiploid group, 7 (22.5%) had modal<br />

chromosome number as 51-60 followed by 2n = 47-50 (three<br />

patients, 6.5%). The chromosomes (Chr) 2, 10, 12,15,17,19<br />

were commonly deleted in hypodiploid cell lines whereas<br />

gain of Chr 4, 8, 10,14 and 20 were observed in hyperdiploid<br />

group. Translocation t (10;14), t (9;22), t (2;22), t (8;22) and t<br />

(4;11) were seen in 04 (12.8%), 03 (9.6%), 02 (6.4%each) and<br />

one patient (3.2%) respectively.<br />

Conclusion: Adverse cytogenetic parameters such as<br />

hypodiploidy and translocations such as t (10;14), t (9;22), t<br />

(2;22), t (8;22) and t (4;11) were more common in our cohort<br />

of patients.<br />

KEY WORDS: chromosomes, cytogenetics, G-Banding, ploidy, translocations<br />

INTRODUCTION<br />

Molecular genetic analysis of acute leukemia has<br />

been at the forefront of research in the pathogenesis of<br />

cancer because the presence of recurring chromosomal<br />

abnormalities provides immediate clues to the genetic<br />

events leading to leukemia and the means to clone and<br />

identify the dysregulated oncogenes. In the majority<br />

of acute leukemia and 54 to 78% of adult acute<br />

myeloid leukemia (AML), cytogenetic abnormalities<br />

are detected on karyotype analysis of peripheral<br />

blood or bone marrow. Large clinical studies of both<br />

acute myeloid and lymphoblastic leukemia (ALL)<br />

have demonstrated that pretreatment diagnostic<br />

cytogenetics is one of the most valuable prognostic<br />

indicators for acute leukemia [1] . Recognized risk<br />

groups defined by age, sex, presenting total leukocyte<br />

count (TLC), <strong>org</strong>anomegaly, mediastinal adenopathy<br />

have been shown to contain subgroups of patients<br />

with different outcome predicted by karyotype,<br />

early response to therapy, immunophenotype, and<br />

molecular genetic abnormality. Hyperdiploid patients<br />

with modal chromosomal numbers greater than 50<br />

fare best, whereas pseudodiploidy and hypodiploidy<br />

are associated with generally poor response. Patients<br />

with any translocation have a six fold greater risk<br />

of early treatment failure than those without such<br />

abnormalities [2] .<br />

The aim of the present article was to study the<br />

clinicopathological features and various chromosomal<br />

abnormalities in pediatric ALL with a brief review of<br />

literature.<br />

SUBJECTS AND METHODS<br />

This was a prospective study done over a period<br />

of one year (December 2008 to November 2009). The<br />

Institutional Ethics Committee had approved the study<br />

and written consent was obtained from the parents of the<br />

patients. Forty-four (44) patients (30 male, 14 female,<br />

M:F = 2:1) of newly diagnosed pediatric (1 to 14 years)<br />

ALL were included for cytogenetic analysis. Infants,<br />

those in induction and maintenance chemotherapy<br />

and relapse were excluded from the study. The<br />

Address correspondence to:<br />

Dr Somanath Padhi, MD, Assistant Professor in Pathology, Pondicherry Institute of Medical Sciences, Ganapathichettykulam, Village-20, Kalapet,<br />

Puducherry, India, 605014. Tel: +91-8940108170, E-Mail: somanath.padhi@gmail.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!